Ronald Paulus, MD, MBA, President and CEO of Mission Health, stated the following in a July 2, 2017 news release titled "Mission Health's President & CEO Clarifies Position on Medical Marijuana, Differs from July 1 Asheville Citizen-Times Report," available at

“The most absurd aspect of current marijuana policy is its DEA classification as a Schedule 1 drug, defined as having no accepted medical use and a high potential for abuse. Other Schedule 1 drugs include LSD and heroin.  I believe that drugs should be classified based upon science, not emotion. Schedule 1 classification significantly impairs the ability to do rigorous research, which prevents the true pros and cons of medical marijuana from being discerned.”

July 2, 2017